Literature DB >> 12135478

Ruk is ubiquitinated but not degraded by the proteasome.

Frédérique Verdier1, Taras Valovka, Alexander Zhyvoloup, Ludmila B Drobot, Vladimir Buchman, Mike Waterfield, Ivan Gout.   

Abstract

The regulator of ubiquitous kinase (Ruk) protein, also known as CIN85 or SETA, is an adaptor-type protein belonging to the CD2AP/CMS family. It was found in complexes with many signaling proteins, including phosphoinositol (PtdIns) 3-kinase (EC 2.7.1.137), Cbl, GRB2, p130Cas and Crk. Functional analysis of these interactions, implicated Ruk in the regulation of apoptosis, receptor endocytosis and cytoskeletal rearrangements. We have recently demonstrated that overexpression of Ruk induces apoptotic death in neurons, which could be reversed by activated forms of PtdIns 3-kinase and PKB/Akt. Furthermore, Ruk was shown to be a negative regulator of PtdIns 3-kinase activity through binding to its P85 regulatory subunit [Gout, I., Middleton, G., Adu, J., Ninkina, N. N., Drobot, L. B., Filonenko, V., Matsuka, G., Davies, A.M., Waterfield, M. & Buchman, V. L. (2000) Embo J.19, 4015-4025]. Here, we report for the first time, that all three isoforms of Ruk (L, M and S) are ubiquitinated. Specific interaction between the E3 ubiquitin ligase Cbl and all three Ruk isoforms was demonstrated by coexpression studies in Hek293 cells. The interaction of Ruk M and S isoforms with Cbl was found to be mediated via heterodimerization with Ruk L. The use of proteosomal and lysosomal inhibitors clearly indicated that ubiquitination of Ruk L does not lead to its degradation. Based on this study, we propose a possible mechanism for the regulation of Ruk function by ubiquitination.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12135478     DOI: 10.1046/j.1432-1033.2002.03031.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  8 in total

Review 1.  Cargo- and compartment-selective endocytic scaffold proteins.

Authors:  Iwona Szymkiewicz; Oleg Shupliakov; Ivan Dikic
Journal:  Biochem J       Date:  2004-10-01       Impact factor: 3.857

2.  CD2AP regulates SUMOylation of CIN85 in podocytes.

Authors:  Irini Tossidou; Rainer Niedenthal; Malte Klaus; Beina Teng; Kirstin Worthmann; Benjamin L King; Kevin J Peterson; Hermann Haller; Mario Schiffer
Journal:  Mol Cell Biol       Date:  2011-12-27       Impact factor: 4.272

3.  Epidermal growth factor receptor signaling intensity determines intracellular protein interactions, ubiquitination, and internalization.

Authors:  Mirko H H Schmidt; Frank B Furnari; Webster K Cavenee; Oliver Bögler
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-06       Impact factor: 11.205

4.  A novel function of eIF2alpha kinases as inducers of the phosphoinositide-3 kinase signaling pathway.

Authors:  Shirin Kazemi; Zineb Mounir; Dionissios Baltzis; Jennifer F Raven; Shuo Wang; Jothi-Latha Krishnamoorthy; Olivier Pluquet; Jerry Pelletier; Antonis E Koromilas
Journal:  Mol Biol Cell       Date:  2007-06-27       Impact factor: 4.138

5.  Differential Contributions of Ubiquitin-Modified APOBEC3G Lysine Residues to HIV-1 Vif-Induced Degradation.

Authors:  Tiffany Turner; Qiujia Shao; Weiran Wang; Yudi Wang; Chenliang Wang; Ballington Kinlock; Bindong Liu
Journal:  J Mol Biol       Date:  2016-06-10       Impact factor: 5.469

6.  Regulation of mouse hepatic genes in response to diet induced obesity, insulin resistance and fasting induced weight reduction.

Authors:  R Michael Raab; John Bullen; Joanne Kelleher; Christos Mantzoros; Gregory Stephanopoulos
Journal:  Nutr Metab (Lond)       Date:  2005-06-28       Impact factor: 4.169

7.  CIN85 Deficiency Prevents Nephrin Endocytosis and Proteinuria in Diabetes.

Authors:  Beina Teng; Patricia Schroder; Janina Müller-Deile; Heiko Schenk; Lynne Staggs; Irini Tossidou; Ivan Dikic; Hermann Haller; Mario Schiffer
Journal:  Diabetes       Date:  2016-08-16       Impact factor: 9.461

8.  Distinct ubiquitin binding modes exhibited by SH3 domains: molecular determinants and functional implications.

Authors:  Jose L Ortega Roldan; Salvador Casares; Malene Ringkjøbing Jensen; Nayra Cárdenes; Jerónimo Bravo; Martin Blackledge; Ana I Azuaga; Nico A J van Nuland
Journal:  PLoS One       Date:  2013-09-11       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.